15 Results for "

Vonoprazan

" in MedChemExpress (MCE) Product Catalog:
Products (15)

15 Results for "Vonoprazan" in MCE Product Catalog:

6
6 Publications Verification
Cat. No.: HY-100007
CAS No.: 881681-00-1
Purity:  99.40%
Synonyms: TAK-438 free base
Target:  

Proton Pump Bacterial

Research Areas:  

Infection

Vonoprazan (TAK-438 free base), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan inhibits H +,K +-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease. Vonoprazan can be used for eradication of Helicobacter pylori .
loading...
    loading...
6
6 Publications Verification
Cat. No.: HY-15295
CAS No.: 881681-01-2
Purity:  101.1%
Synonyms: TAK-438
Target:  

Proton Pump

Research Areas:  

Infection Inflammation/Immunology

Vonoprazan Fumarate (TAK-438), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan Fumarate inhibits H +,K +-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan Fumarate is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease .
loading...
    loading...
6
6 Publications Verification
Cat. No.: HY-100007A
CAS No.: 1957202-44-6
Synonyms: TAK-438 hydrochloride
Target:  

Proton Pump Bacterial

Research Areas:  

Infection Endocrinology Cancer

Vonoprazan hydrochloride, a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan hydrochloride inhibits H +,K +-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan hydrochloride is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease. Vonoprazan hydrochloride can be used for eradication of Helicobacter pylori .
loading...
    loading...
Cat. No.: HY-W728503S
N-Nitroso Vonoprazan-sup>13C,d3 is the sup>13C- and deuterium labeled N-Nitroso Vonoprazan. N-Nitroso Vonoprazan is an impurity of Vonoprazan .
loading...
    loading...
Cat. No.: HY-15295R
CAS No.: 881681-01-2
Synonyms: TAK-438 (Standard)
Research Areas:  

Metabolic Disease Cancer

Vonoprazan (Fumarate) (Standard) is the analytical standard of Vonoprazan (Fumarate). This product is intended for research and analytical applications. Vonoprazan Fumarate (TAK-438), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan Fumarate inhibits H+,K+-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan Fumarate is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease .
loading...
    loading...
Cat. No.: HY-Z3421S1
Vonoprazan-d4 (fumarate) is deuterium labeled 1-(5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine fumarate (Vonoprazan Impurity).
loading...
    loading...
Cat. No.: HY-Z3421S
Vonoprazan-d3 fumarate is the deuterium labeled Vonoprazan fumarate (HY-15295). Vonoprazan Fumarate (TAK-438), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan Fumarate inhibits H+,K+-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan Fumarate is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease .
loading...
    loading...
Cat. No.: HY-100007R
CAS No.: 881681-00-1
Synonyms: TAK-438 free base (Standard)
Research Areas:  

Endocrinology

Vonoprazan (Standard) is the analytical standard of Vonoprazan. This product is intended for research and analytical applications. Vonoprazan (TAK-438 free base), a proton pump inhibitor (PPI), is a potent and orally active potassium-competitive acid blocker (P-CAB), with antisecretory activity. Vonoprazan inhibits H +,K +-ATPase activity in porcine gastric microsomes with an IC50 of 19 nM at pH 6.5. Vonoprazan is developed for the research of acid-related diseases, such as gastroesophageal reflux disease and peptic ulcer disease. Vonoprazan can be used for eradication of Helicobacter pylori .
loading...
    loading...
Cat. No.: HY-W096504
CAS No.: 56448-22-7
Target:  

Drug Intermediate

Research Areas:  

Others

Vonoprazan impurity 4 is an impurity of Vonoprazan (HY-100007).
loading...
    loading...
Cat. No.: HY-Z3759
CAS No.: 312307-38-3
Target:  

Drug Intermediate

Research Areas:  

Others

Vonoprazan impurity 7 is an impurity of Vonoprazan (HY-100007).
loading...
    loading...
Cat. No.: HY-Z2106S
Vonoprazan impurity 11-d5 (fumarate) is deuterium labeled 1-(5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)-N-((5-(2-fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl)methyl)-N-methylmethanamine (Vonoprazan Impurity).
loading...
    loading...
Cat. No.: HY-Z2063
CAS No.: 1240948-72-4
Target:  

Drug Intermediate

Research Areas:  

Others

Vonoprazan impurity 6 is an impurity of Vonoprazan (HY-100007).
loading...
    loading...
Cat. No.: HY-Z2335
CAS No.: 1807642-39-2
Target:  

Drug Intermediate

Research Areas:  

Others

Vonoprazan impurity 1 is an impurity of Vonoprazan (HY-100007).
loading...
    loading...
Cat. No.: HY-Z3136
CAS No.: 2169267-53-0
Target:  

Drug Intermediate

Research Areas:  

Others

Vonoprazan impurity 46 is an impurity of Vonoprazan (HY-100007).
loading...
    loading...
Cat. No.: HY-181038
Target:  

Bacterial

Research Areas:  

Infection

Rifabutin-vonoprazan conjugate 1 is an orally active acid-responsive bifunctional molecule. Rifabutin-vonoprazan conjugate 1 exhibits anti-Helicobacter pylori activity (MIC ≤ 0.125 μg/mL) and acid-suppressive effects (acid inhibition rate > 85% at a dose of 2 mg/kg). Rifabutin-vonoprazan conjugate 1 also demonstrates anti-ulcer activity. Rifabutin-vonoprazan conjugate 1 can be used in research related to Helicobacter pylori infection and gastric ulcer .
loading...
    loading...
  • 1